315183-21-2(PAC1) Product Description

PAC1 4-(Phenylmethyl)-1-piperazineaceticacid[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide PAC1,4-(PhenylMethyl)-1-piperazineaceticacid[[2-hydroxy-3-(2-propenyl)phenyl]Methylene]hydrazide 4-(Phenylmethyl)-1-piperazineacetic acid 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide PAC-1,PAC1 Procaspase activating coMpound 1 (E)-N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide 4-(Phenylmethyl)-1-piperazineacetic acid 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide PAC-1 PAC 1 4-(Phenylmethyl)-1-piperazineacetic acid 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide (4-Benzylpiperazino)acetic acid (3-allyl-2-hyroxybenzylidene)hydrazide 1-Piperazineacetic acid, 2-(phenylmethyl)-,[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hyrrazide ADCYAP1R1 Pac1 receptor Pac1 receptors PAC1-R PACAP receptor 1 ANTI-DUSP2 (C-TERM) antibody produced in rabbit Dual specificity protein phosphatase 2 Dual specificity protein phosphatase PAC-1 DUSP2 Anti-DUSP2 (C-terminal) antibody produced in rabbit PAC 1, >=98% PAC-1 10MG PAC-1, 98%, a procaspase-3 activatior CS-243 PAC 1 - Procaspase activating compound 1 1-Piperazineacetic acid, 4-(phenylmethyl)-, 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide PAC-1 >=98% (HPLC) PAC1 USP/EP/BP PAC-1 (VO-100) N'-(3-Allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide PAC1（b） N'-(3-Allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide 315183-21-2 Inhibitor Inhibitors